 |
|
Clinical Use of Thrombolytic Agents in Venous Thromboembolism
Arthur A. Sasahara, MD;
G. V. R. K. Sharma, MD;
Donald E. Tow, MD;
Kevin M. McIntyre, MD;
Alfred F. Parisi, MD;
Giuseppe Cella, MD
Arch Intern Med. 1982;142(4):684-688.
Abstract
• The use of thrombolytic agents in venous thromboembolism has been shown to be highly effective. Patients treated with lytic agents show more rapid clot resolution and lung reperfusion and more rapid and greater reversal of the abnormal hemodynamic responses to pulmonary embolism than patients receiving heparin. Moreover, lytic therapy removes thromboemboli more completely from the pulmonary microcirculation, whereas residual thromboemboli tend to accumulate with heparin therapy. In addition, lytic therapy tends to preserve the venous valves, whereas distortion and destruction occur with heparin therapy. Hence, lytic therapy confers a number of short- and long-term benefits not observed with heparin therapy.
(Arch Intern Med 1982;142:684-688)
Author Affiliations
From the Medical (Drs Sasahara, Sharma, McIntyre, and Parisi), Nuclear Medicine (Dr Tow), and Research (Dr Cella) Services, West Roxbury (Mass) Veterans Administration Medical Center; and the Departments of Medicine (Drs Sasahara, Sharma, McIntyre, Parisi, and Cella) and Nuclear Medicine (Dr Tow), Brigham and Women's Hospital and Harvard Medical School, Boston.
Footnotes
Accepted for publication April 27, 1981.
Reprint requests to Medical Service, West Roxbury Veterans Administration Medical Center, 1400 Veterans of Foreign Wars Pkwy, West Roxbury, MA 02132 (Dr Sasahara).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Improved Lung Function by Urokinase Infusion in Canine Lung Transplantation Using Non-Heart-Beating Donors
Umemori et al.
Ann. Thorac. Surg. 1995;59:1513-1518.
ABSTRACT
| FULL TEXT
Thrombolytic Therapy of AxillarySubclavian Venous Thrombosis
Landercasper et al.
Arch Surg 1987;122:1072-1075.
ABSTRACT
Prevention of Clot Formation in Cat Retinal Vein by Systemic and Subconjunctival Urokinase
Levinger et al.
Arch Ophthalmol 1987;105:554-558.
ABSTRACT
Massive Pulmonary Embolism: Short-Term Effects of Thrombolytic Treatment
Grau et al.
ANGIOLOGY 1986;37:832-839.
ABSTRACT
Management of Effort Thrombosis with Low-Dose Streptokinase
Webb and Kerstein
VASC ENDOVASCULAR SURG 1985;19:200-206.
ABSTRACT
Streptokinase-Induced Subcapsular Hematoma of the Liver
Willis and Bailey
Arch Intern Med 1984;144:2084-2085.
ABSTRACT
Is Streptokinase Safe During Menses?
Simel et al.
Arch Intern Med 1984;144:841-842.
ABSTRACT
Pulmonary Thromboembolism: Diagnosis and Treatment
Sasahara et al.
JAMA 1983;249:2945-2950.
ABSTRACT
|
